RA

Rita Agarwal

Director Director DIN 02224512
DIN 02224512 First appointment Dec 2005 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2005
Shareholding value Locked Premium profile

About Rita Agarwal

Rita Agarwal has 20 years in corporate governance. Formerly with 1 company, such as Sarillon Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02224512
Primary Designation Director
First Appointment 07 Dec 2005
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Sarillon Drugs Private Limited U24230HP2005PTC029295
Director 07 Dec 2005 2005 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sarillon Drugs Private Limited
Premium access

Shareholding and investment profile for Rita Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rita Agarwal

Rita Agarwal has 20 years in corporate governance. Formerly with 1 company, such as Sarillon Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

Rita Agarwal is associated with 0 companies as a director.

Rita Agarwal has expertise in General Business.

Rita Agarwal has 20 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available